Global urinalysis market is
expected to reach over USD 2.14 billion by 2022, according to a new report by
Grand View Research, Inc.
Automation is a key
technological advancement affecting the efficiency and accuracy delivered by
the new generation urinalysis devices and hence, the persistent demand for
novel urinalysis instruments and consumables. For instance, the automatic
bench-top and portable biochemical urine analyzers, automated urine sediment
analyzers (Aution Hybrid AU-4050 from Arkray),and automated microscopic urine
analyzers (Sysmex UF-1000i) are the next generation, advanced instruments is
anticipated to foster the urinalysis market growth.
The introduction of CLIA-waived
urine reagent strips such as CLIA-URS-10, CLIA-URS-10-3PROMO, and
CLIA-URS-10-10 provide for an effective screening tool for rapid testing in
urine analysis which are estimated to enhance the usage rates of urinalysis
reagents thus accentuating the market growth over the forecast period.
The target population base for
urinalysis market is increasing owing to, factors such as the rising prevalence
of target diseases, misdiagnosis, and low awareness levels pertaining to urine
analysis in low-income countries. High incidences of obesity coupled with
hypertension, diabetes, and other chronic disorders foster the growth of the
urinalysis market.
In depth research report on Urinalysis Market
Further key findings from the study suggest:
·
Urinary Tract Infections
(UTIs)dominated the application segment in 2014. The foremost factor
responsible for its high share is the rising prevalence of UTIs, especially in
females. However, diabetes is estimated to be the fastest growing application
segment with a CAGR of over 10% during the forecast period owing to a surge in
the demand for automated and user-friendly urinalysis products for long-term
diabetes management.
·
Consumables held the largest
share with revenue generation of over USD 1 million in 2014. The increasing
usage of test strips and reagents for urinalysisis one of the major factors
that are attributed to its large market share. However, the instrument segment
is expected to witness the fastest growth with a CAGR of over 7%. Automation of
instruments with improved efficiency and reliability is expected to govern this
segment’s growth.
·
The home healthcare segment, on
the other hand, is anticipated to grow at a substantial rate over 7.5%. The
availability of technologically enabled point-of-care urinalysis systems, such
as CLINITEK Status, is a key factor expected to reinforce the market growth.
·
North America dominated the
overall urinalysis market with a revenue generation of over USD 540 million in
2014. The introduction of advanced urine analyzers by key market players in the
U.S., favorable government initiatives ensuring the betterment of healthcare
testing, and the high amount of healthcare spending in this region are the key
factors attributing to the largest market share of this region.
·
Key players of this market
include Roche Diagnostics, Alere, Inc., Siemens Healthcare, Bio-Rad, ARKRAY,
Inc., Mindray, and Sysmex.
·
Market participants are
constantly engaged in the introduction of novel diagnostic products in an
attempt to ensure their sustainability and increase the penetration of their
product portfolio. For instance, in June 2014, Roche launched a fully automated
urine testing analyzer named Cobas 6500 with an objective to enhance staff
safety and increase the result reliability.
Grand View Research has
segmented the global urinalysis market on the basis of product, application,
end-use, and region:
Global Urinalysis Product Outlook (Revenue, USD Million,
2015 - 2022)
·
Instruments
·
Biochemical urine analyzers
·
Automated biochemical analyzers
·
Semi-automated biochemical
analyzers
·
Automated urine sediment
analyzers
·
Microscopic urine analyzers
·
Flow-cytometric urine analyzers
·
Consumables
·
Dipsticks
·
Reagents
·
Disposables
Global Urinalysis Application Outlook (Revenue, USD
Million, 2015 - 2022)
·
UTIs
·
Diabetes
·
Kidney Disease
·
Hypertension
·
Liver disease
·
Others
Global Urinalysis End-use Outlook (Revenue, USD Million,
2015 - 2022)
·
Hospitals
·
Clinical Laboratories
·
Home healthcare
·
Research and academics
·
Others
Urinalysis Regional Outlook (Revenue, USD Million, 2015 -
2022)
·
North America
·
U.S.
·
Canada
·
Europe
·
U.K
·
Germany
·
Asia Pacific
·
Japan
·
China
·
Latin America
·
Brazil
·
MEA
·
South Africa
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment